Doer Biologics Begins Phase II Study of DR10624 for Steatotic Liver Disease
China-based Zhejiang Doer Biologics Co., Ltd has announced the first patient dosing in a Phase...
Boehringer Ingelheim Partners with Tessellate Bio on ALT Cancer Therapies
Boehringer Ingelheim (BI), a German pharmaceutical leader, has entered into a strategic collaboration and global...
Genentech Collaborates with Repertoire Immune Medicines on Autoimmune Disease Therapies
Genentech, a subsidiary of Swiss pharmaceutical leader Roche (SWX: ROG, OTCMKTS: RHHBY) , announced a collaboration...
AstraZeneca Expands AI Partnership with Tempus AI and Pathos AI for Oncology Research
UK pharmaceutical leader AstraZeneca (AZ, NASDAQ: AZN) has expanded its collaboration with US-based Tempus AI,...
Boston Scientific Reports 20.9% Revenue Growth in Q1 2025 Financial Results
US medical technology giant Boston Scientific Corporation (NYSE: BSX) released its Q1 2025 financial report,...
Roche Launches Navify Chest Pain Triage Algorithm With CE Mark
Swiss healthcare giant Roche (SWX: ROG, OTCMKTS: RHHBY) announced today that it has received CE...
Trump Administration Considers Tying US Drug Prices to International Benchmarks
Reuters reported that the Trump administration is exploring a policy to tie domestic drug prices...
Baheal Partners with Jiluntai for Commercialization of Technetium-99m-labeled Imaging Agent
China-based health services and distribution giant Baheal Pharmaceutical Group (SHE: 301015) has entered into a...
PingAn Good Doctor Reports Q1 2025 Revenue Growth and Net Profit Turnaround
China-based Ping An Healthcare and Technology Co., Ltd (HKG: 1833), also known as PingAn Good...
MicroPort MedBot Gains NMPA Clearance for Toumai’s Remote Surgery Across Departments
Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) has announced receiving clearance from China’s National...
QYuns Therapeutics Signs Global Licensing Deal with Caldera for Autoimmune BsAb
China-based Jiangsu QYuns Therapeutics Co., Ltd (HKG: 2509) has entered into a licensing agreement with...
Roche Unveils $50 Billion Five-Year US Investment Plan to Expand Manufacturing and R&D
Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) has announced a five-year investment plan totaling...
China Medical System Announces Spin-off of Dermavon for HKEX IPO
China Medical System Holdings Limited (CMS; HKG: 0867) has announced the spin-off of its dermatology-focused...
BMS’s Cobenfy Shows Promise in Phase III ARISE Trial for Schizophrenia
Bristol-Myers Squibb (BMS, NYSE: BMY) has announced top-line results from the Phase III ARISE trial...
CSPC Gains NMPA Approval for Phase III Trial of Prusogliptin/Metformin FDC
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has secured approval from the National Medical Products...
CSPC Pharmaceutical Gains FDA IND Clearance for JMT203 in Cancer Cachexia
China-based CSPC Pharmaceutical Group Limited (HKG: 1093) has obtained Investigational New Drug (IND) clearance from...
Grand Pharma Secures NMPA Approval for Fluticasone Nasal Spray
China-based Grand Pharmaceutical Group Co., Ltd. (HKG: 0512) has obtained marketing authorization from China’s National...
Biokin Receives NMPA Approval for CD33 ADC in AML Trial
China-based Sichuan Biokin Pharmaceutical Co., Ltd (SHA: 688506) has announced that it has received approval...
Fujifilm Diosynth Secures $3 Billion US Manufacturing Pact with Regeneron
FUJIFILM Diosynth Biotechnologies (FDB), a leading global contract development and manufacturing organization (CDMO) specializing in...
Hotgen Biotech Injects RMB 300 Million into Subsidiary Sungen Bio for Biologic R&D
China’s Hotgen Biotech Co., Ltd (SHA: 688068) has announced a strategic capital injection plan, partnering...